Respiro inhaler tracking systems are increasingly becoming the most adopted course of managing and treating respiratory diseases. There has been increasing in a number of companies that are implementing digital technologies in their products in order to provide an enhanced and efficient way of managing chronic obstructive pulmonary disease and asthma. Owing to their potential benefits over conventional devices, chiefly in terms of tracking drug intake with the help of digital data by gathering data from the sensor and alerting patients through timely notifications, respire inhaler tracking systems are gaining widespread acceptance across the globe.

Market Dynamics

For COPD and asthma patients, respire inhaler tracking systems are considered the most effective route of delivering medications in appropriate time to the respiratory system. In order to avoid the possibility of medical complications due to missed dose of an indication, respire inhaler tracking have been devised. Rising awareness about this approach in the management of COPD and asthma is expected to be the major factor driving the market growth. Owing to the rising levels of air pollution and rising number of smokers across the globe, the market is anticipated to be driven due to rising incidences of respiratory disorders such as COPD and asthma, chiefly.

Report Coverage

Market Participants

Some of the major players in the global respire inhaler tracking market include Aristopharma Ltd, Intas Pharmaceuticals, GlaxoSmithKline Plc., Merck & Co Inc., and SRS Pharmaceuticals Pvt Ltd. among others

Market Segmentation

Market By Disease Type

• COPD
• Asthma
• Others

Market By End Users

• Hospitals
• Clinics
• Research Institutes

Market By Geography

• North America
  • U.S.
  • Canada
  • Mexico

• Europe
  • UK
  • Germany
  • France
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America

• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Rest of MEA